Clinical Trial Update: LOXL1 Polymorphism in Pseudoexfoliation Syndrome

View source ↗

Summary

Update on a clinical trial investigating LOXL1 gene polymorphisms in pseudoexfoliation syndrome. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudoexfoliation Syndrome

Snippet

Sponsor: Samsung Medical Center | Conditions: Pseudoexfoliation Syndrome | Status: UNKNOWN